$32.45
2.61% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Scholar Rock Holding Corp. Stock price

$32.45
+1.05 3.34% 1M
-9.53 22.70% 6M
-10.77 24.92% YTD
+23.02 244.11% 1Y
+14.87 84.58% 5Y
+16.95 109.35% 10Y
+16.95 109.35% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.87 2.61%
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Key metrics

Market capitalization $3.08b
Enterprise Value $2.77b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 9.86
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-270.73m
Free Cash Flow (TTM) Free Cash Flow $-230.19m
Cash position $364.38m
EPS (TTM) EPS $-2.36
P/E forward negative
P/S forward 432.72
EV/Sales forward 388.53
Short interest 26.51%
Show more

Is Scholar Rock Holding Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Scholar Rock Holding Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Scholar Rock Holding Corp. forecast:

10x Buy
100%

Analyst Opinions

10 Analysts have issued a Scholar Rock Holding Corp. forecast:

Buy
100%

Financial data from Scholar Rock Holding Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 81 81
49% 49%
-
- Research and Development Expense 190 190
41% 41%
-
-269 -269
44% 44%
-
- Depreciation and Amortization 1.73 1.73
36% 36%
-
EBIT (Operating Income) EBIT -271 -271
43% 43%
-
Net Profit -264 -264
44% 44%
-

In millions USD.

Don't miss a Thing! We will send you all news about Scholar Rock Holding Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Scholar Rock Holding Corp. Stock News

Neutral
Business Wire
about 20 hours ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that the company granted inducement equity awards covering an aggregate of 309,700 shares of its common...
Neutral
Business Wire
9 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that David L. Hallal, Chief Executive Officer, and members of management will participate in a fireside chat at the 46...
Neutral
Business Wire
12 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that Rebecca McLeod has been appointed to the newly created role of Chief Brand Officer and U.S. General Manager. In t...
More Scholar Rock Holding Corp. News

Company Profile

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Head office United States
CEO David Hallal
Employees 128
Founded 2012
Website scholarrock.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today